Association of p53 Arg72Pro and MDM2 SNP309 polymorphisms with glioma
“Association of p53 Arg72Pro and MDM2 SNP309 polymorphisms with glioma”, vol. 11, pp. 3618-3628, 2012.
, Epidemiological studies of the association of variants p53 Arg72Pro and MDM2 single-nucleotide polymorphism 309 (SNP309) with glioma risk have produced inconsistent results. The aim of the current study was to evaluate the association of these 2 variants with glioma susceptibility using a meta-analysis approach. For p53 Arg72Pro, 10 case-control studies including 2587 glioma patients and 4061 unrelated controls were identified.